In addition to exercise and a balanced diet, supplements like omega-3 can boost cardiovascular health and reduce the risk of ...

Patients taking Kerendia saw significant reduction in cardiovascular death and hospitalization and urgent visits for heart ...

Rocket Pharmaceuticals received a regenerative medicine advanced therapy designation from the Food and Drug Administration for its heart disease treatment.

The FDA expanded the indication for finerenone (Kerendia) in heart failure (HF), drug manufacturer Bayer announced.

The drug is now approved for treating people with an LVEF of at least 40%, with or without chronic kidney disease.

The approval was supported by data from the randomized, double-blind, placebo-controlled, event-driven phase 3 FINEARTS-HF study.

With India witnessing a quiet explosion in heart failure cases, many striking working-age adults, STAR Hospitals has launched ...

The use of SGLT2 inhibitors has been a game-changer in the treatment of heart failure (HF). Now, another drug class has ...

Following priority review, the U.S. Food and Drug Administration approved Bayer's Kerendia (finerenone) for the treatment of ...

A newly developed artificial intelligence (AI) tool, that uses data from the low-cost electrocardiogram (ECG), may be more ...

Piedmont has expanded access to outpatient heart failure management with a new heart failure clinic at Piedmont Newton ...

Discover how MemorialCare's Women's Heart Center at Long Beach is tackling the leading killer of women, heart disease, ...